Harmony Biosciences Holdings, Inc. financial data

Symbol
HRMY on Nasdaq
Industry
Pharmaceutical Preparations
Location
630 W Germantown Pike, Suite 215, Plymouth Meeting, PA
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 321 % -29.3%
Quick Ratio 3.8 % -19.1%
Debt-to-equity 64.5 % -3.28%
Return On Equity 23 % -52%
Return On Assets 14 % -51.3%
Operating Margin 27.1 % -7.78%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 56.8M shares -5.28%
Common Stock, Shares, Outstanding 56.8M shares -5.28%
Entity Public Float 1.17B USD -13.6%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 56.8M shares -5.29%
Weighted Average Number of Shares Outstanding, Diluted 57.5M shares -5.27%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 656M USD +31.5%
Research and Development Expense 134M USD +69.3%
Selling and Marketing Expense 106M USD +19.6%
General and Administrative Expense 103M USD +16.3%
Operating Income (Loss) 178M USD +21.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 165M USD +23.2%
Income Tax Expense (Benefit) 50M USD +3.14%
Net Income (Loss) Attributable to Parent 115M USD -42.6%
Earnings Per Share, Basic 1.99 USD/shares -41%
Earnings Per Share, Diluted 1.96 USD/shares -40.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 317M USD -0.04%
Accounts Receivable, after Allowance for Credit Loss, Current 83.2M USD +30.3%
Inventory, Net 5.64M USD +16.3%
Other Assets, Current 6.51M USD -0.66%
Assets, Current 458M USD +0.59%
Deferred Income Tax Assets, Net 180M USD +92.6%
Property, Plant and Equipment, Net 754K USD +31.8%
Operating Lease, Right-of-Use Asset 2.51M USD +21.9%
Intangible Assets, Net (Excluding Goodwill) 125M USD -16%
Other Assets, Noncurrent 6.47M USD +163%
Assets 858M USD +12.9%
Accounts Payable, Current 22.7M USD +246%
Employee-related Liabilities, Current 9.64M USD
Accrued Liabilities, Current 91.6M USD +44.2%
Liabilities, Current 147M USD +57.5%
Operating Lease, Liability, Noncurrent 854K USD +88.9%
Other Liabilities, Noncurrent 1.8M USD +21.4%
Liabilities 320M USD +16.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -234K USD +55.2%
Retained Earnings (Accumulated Deficit) -93.4M USD +55.2%
Stockholders' Equity Attributable to Parent 539M USD +11%
Liabilities and Equity 858M USD +12.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 31.1M USD -26.8%
Net Cash Provided by (Used in) Financing Activities -3.63M USD -207%
Net Cash Provided by (Used in) Investing Activities -6.19M USD -246%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 56.8M shares -5.28%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 21.3M USD -51.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 318M USD -0.03%
Interest Paid, Excluding Capitalized Interest, Operating Activities 4.59M USD -8.61%
Deferred Tax Assets, Valuation Allowance 5.45M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 150M USD +73.4%
Operating Lease, Liability 2.64M USD +18%
Depreciation 163K USD +58.3%
Payments to Acquire Property, Plant, and Equipment 5K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 115M USD -42.3%
Lessee, Operating Lease, Liability, to be Paid 2.8M USD +20.7%
Operating Lease, Liability, Current 1.79M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Two 495K USD +181%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.25M USD +10.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +63.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 164K USD +92.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 12K USD -40%
Deferred Tax Assets, Operating Loss Carryforwards 45.9M USD +621%
Operating Lease, Payments 561K USD +31.1%
Amortization of Intangible Assets 23.8M USD 0%
Share-based Payment Arrangement, Expense 38.2M USD +31.9%
Interest Expense 4.54M USD -20.9%